Top

Annals of Nuclear Medicine

Published in:

01-04-2011 | Original Article

Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging

Authors: Akira Toriihara, Katsuya Yoshida, Isao Umehara, Hitoshi Shibuya

Published in: Annals of Nuclear Medicine | Issue 3/2011

Abstract

Objective

To evaluate the normal variants of the physiological bowel 2-deoxy-2-[¹⁸F]fluoro-d-glucose (FDG) uptake in dual-time-point positron emission tomography/computed tomography (PET/CT).

Methods

We performed a retrospective review of 206 consecutive asymptomatic subjects who underwent whole-body FDG PET/CT for medical checkup in our institution. The criteria for exclusion of the subjects from this study were as follows: history of abdominal surgeries or endoscopic mucosal resection, history of any malignant tumors, symptoms of diarrhea or constipation, a positive fecal occult blood test, elevated serum carcinoembryonic antigen (CEA) level, and hyperglycemia (more than 110 mg/dl). A total of 39 subjects (32 males, 7 females, mean age 58.1 years old) were enrolled in this retrospective study. Two radiologists evaluated the dual-time-point FDG PET/CT images of these 39 subjects, retrospectively. FDG uptakes in 5 areas (small bowel (SB), cecum and ascending colon (AC), transverse colon (TC), descending colon (DC), and rectosigmoid colon (RS)) were scored visually in comparison with the activity in the liver (0 = no uptake, 1 = activity less than that in the liver, and 2 = activity equal to or greater than that in the liver) in the early and delayed image. The scores decided by two radiologists were averaged and this average score was defined as the bowel uptake score (BUS). For 34 areas with the BUS of 2 in either the early or delayed images, the maximum standardized uptake values (SUV_max) were measured for semiquantitative analysis. Wilcoxon’s signed rank test and paired t test were adopted for the statistical analyses.

Results

The average BUS in the early/delayed images was 1.19/1.17 (SB), 0.81/1.23 (AC), 0.10/0.35 (TC), 0.35/0.59 (DC), and 1.17/1.54 (RS), respectively. The average SUV_max of the 34 areas with a score of 2 was 3.11 in the early images and 3.76 in the delayed images. The scores in the AC, TC, DC and RS, and the SUV_max were significantly higher in the delayed images (p < 0.05).

Conclusions

Physiological FDG uptake in the colon increases significantly from the early to the delayed phase in dual-time-point PET/CT imaging, which should be carefully taken into consideration in the diagnosis of bowel diseases.

Abouzied MM, Crawford ES, Nabi HA. ¹⁸F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol. 2005;33:145–55.PubMed

Shreve P, Bui CDH. Artifacts and normal variants in FDG PET. In: Wahl RL, editor. Principles and practice of PET and PET/CT. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, a Wolters Kluwer business; 2009. p.139–68.

Prabhakar HB, Sahani DV, Fischman AF, Mueller PR, Blake MA. Bowel hot spots at PET-CT. RadioGraphics. 2007;27:145–59.PubMedCrossRef

Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002;224:783–7.PubMedCrossRef

Gutman F, Alberini JL, Wartski M, Vilain D, Le Stanc E, Sarandi F, et al. Incidental colonic focal lesions detected by FDG PET/CT. Am J Roentgenol. 2005;185:495–500.CrossRef

Otsuka H, Graham MM, Kubo A, Nishitani H. The effect of oral contrast on large bowel activity in FDG-PET/CT. Ann Nucl Med. 2005;19:101–8.PubMedCrossRef

Blake MA, Setty BN, Cronin CG, Kalra M, Holalkere NS, Fischman AJ, et al. Evaluation of the effects of oral water and low-density barium sulphate suspension on bowel appearance on FDG-PET/CT. Eur Radiol. 2010;20:157–64.PubMedCrossRef

Soyka JD, Strobel K, Veit-Haibach P, Schaefer NG, Schmid DT, Tschopp A, et al. Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine. J Nucl Med. 2010;51:507–10.PubMedCrossRef

Emmott J, Sanghera B, Chambers J, Wong WL. The effects of N-butylscopolamine on bowel uptake: an ¹⁸F-FDG PET study. Nucl Med Commun. 2008;29:11–6.PubMedCrossRef

10.

Murphy R, Doerger KM, Nathan MA, Lowe VJ. Pretreatment with diphenoxylate hydrochloride/atropine sulphate (lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis. Mol Imaging Biol. 2009;11:114–7.PubMedCrossRef

11.

Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med. 2001;28:696–703.PubMedCrossRef

12.

Hustinx R, Smith RJ, Benard F, Rosenthal DI, Machtay M, Farber LA, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med. 1999;26:1345–8.PubMedCrossRef

13.

Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point ¹⁸F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43:871–5.PubMed

14.

Boerner AR, Weckesser M, Herzog H, Schmitz T, Audretsch W, Nitz U, et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med. 1999;26:226–30.PubMedCrossRef

15.

Kumar R, Loving VA, Chauhan A, Zhuang H, Mitchell S, Alavi A. Potential of dual-time-point imaging to improve breast cancer diagnosis with ¹⁸F-FDG PET. J Nucl Med. 2005;46:1819–24.PubMed

16.

Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Doi R, et al. Delayed ¹⁸F-fluoro-2-deoxy-d-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer. 2000;89:2547–54.PubMedCrossRef

17.

Lodge MA, Lucas JD, Marsden PK, Cronin BF, O’Doherty MJ, Smith MA. A PET study of ¹⁸FDG uptake in soft tissue masses. Eur J Nucl Med. 1999;26:22–30.PubMedCrossRef

18.

Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, et al. Dual time point ¹⁸F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412–7.PubMed

19.

Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, et al. High and typical ¹⁸F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2008;35:95–9.PubMedCrossRef

Title: Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging
Authors: Akira Toriihara
Katsuya Yoshida
Isao Umehara
Hitoshi Shibuya
Publication date: 01-04-2011
Publisher: Springer Japan
Published in: Annals of Nuclear Medicine / Issue 3/2011
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-010-0439-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging

Abstract

Objective

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2011

Erratum to: Impact of radioguided occult lesion localization on the correct excision of malignant breast lesions: effect of histology and tumor size

Small lesions detectability with the Biograph 16 Hi-Rez PET/CT scanner and fast imaging protocols: performance evaluation using an anthropomorphic thoracic phantom and ROC analyses

Effect of dialysis on cerebral blood flow in depressive end-stage renal disease patients

Present and future of FDG-PET/CT in ovarian cancer

18F-FDG-PET/CT findings in primary pulmonary mixed squamous cell and glandular papilloma

Impact of radioguided occult lesion localization on the correct excision of malignant breast lesions: effect of histology and tumor size